Ley May

Endocanna Health, an industry leader in endocannabinoid system genomic testing, has been granted a first-of-its-kind U.S. patent for its DNA test, enabling hyper-personalized cannabinoid therapies based on user genetics. The patent, "Graphical User Interfaces for Determining Personalized...